Gene patents in the primary prevention of vascular diseases

Area of Science:

• Cardiovascular Research
• Pharmacology
• Biotechnology

Background:

• Atherosclerosis remains a leading cause of mortality globally, with persistent high morbidity despite current treatments.
• Existing therapies for vascular diseases are insufficient, necessitating the identification of novel therapeutic targets.
• Cardiovascular drug discovery requires diverse approaches to evaluate candidate agents for efficacy.

Purpose of the Study:

• To explore gene patenting as a strategy for identifying new therapeutic targets in the primary prevention of vascular diseases.
• To identify promising compounds for prophylactic cardiovascular protection and treatment of related disorders.
• To complement existing therapeutic strategies for atherosclerosis and other vascular conditions.

Main Methods:

• Systematic collection and analysis of articles related to gene patenting in vascular disease prevention.
• Evaluation of identified compounds for potential therapeutic utility in cardiovascular and vascular tissues.
• Review of applications for treating endothelial dysfunction, inflammation, hypertension, and dyslipidemia.

Main Results:

• Gene patenting has emerged as a promising avenue for discovering novel therapeutic targets in vascular disease.
• Identified compounds show potential for prophylactic cardiovascular protection.
• Compounds may be utilized for treating various vascular disorders, including endothelial dysfunction, inflammation, hypertension, and dyslipidemia.

Conclusions:

• Gene patenting offers a valuable approach to uncovering new therapeutic targets for vascular diseases.
• This strategy can lead to the development of novel prophylactic and therapeutic agents.
• Further research into gene patenting holds significant promise for addressing the unmet needs in cardiovascular medicine.